Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccination to Prevent COVID-19 (ACTIVATE II)
NCT04414267Phase 4Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by Hellenic Institute for the Study of Sepsis. Started May 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04414267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414267.